Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-013820

Chief Medical Officer sold 11,945 shares at an average $15.97 ($190,747)

  • Chief Medical Officer acquired 5,375 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rottinghaus Scott T. Chief Medical Officer 2024-07-11 Sale 10b5-1 −4,299 $15.07 $64,786 23,988 D
Rottinghaus Scott T. Chief Medical Officer 2024-07-12 Sale 10b5-1 −2,271 $15.04 $34,156 21,717 D
Rottinghaus Scott T. Chief Medical Officer 2024-07-15 Option exercise 10b5-1 +5,375 $8.99 $48,321 27,092 D
Rottinghaus Scott T. Chief Medical Officer 2024-07-15 Sale 10b5-1 −5,375 $17.08 $91,805 21,717 D
Derivatives
Rottinghaus Scott T. Chief Medical Officer 2024-07-15 Option exercise · Stock Option (Right to Buy) 10b5-1 −5,375 80,625 D
Open-market sales · 11,945 sh · avg $15.97 · $190,747
Loading xslF345X05/form4.xml…